You are here

  • Home
  • Archive
  • Volume 75, Issue Suppl 2
  • SAT0151 Imaging and Histopathological Changes To Tocilizumab in Patients with Moderate To Severe Ra: A Single Centre Randomized Double-Blind Placebo-Controlled Study

Citation Tools

Article menu
Download PDFPDF
Poster Presentations
Rheumatoid arthritis - other biologic treatment
SAT0151 Imaging and Histopathological Changes To Tocilizumab in Patients with Moderate To Severe Ra: A Single Centre Randomized Double-Blind Placebo-Controlled Study

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Zayat A, Wong C, Cuthbert R, et al
SAT0151 Imaging and Histopathological Changes To Tocilizumab in Patients with Moderate To Severe Ra: A Single Centre Randomized Double-Blind Placebo-Controlled Study
Annals of the Rheumatic Diseases 2016;75:720.